Biological E seeks approval for emergency use of Corbevax vaccine for the age group of 12 to 18 years, decision may be taken soon



Covid Vaccination News: Biologicals-E has received its Kovid-19 vaccine ‘Korbevax’ in the age group of 12 to 18 years from the drug regulator of India. Approval for emergency use of The Drug Controller General of India (DGCI) on December 28 approved limited use of Corbevax, the country’s first indigenously developed RBD protein sub-unit vaccine against coronavirus infection, in adults in emergency situations.

According to the Health Ministry, Biologicals-E has conducted the first/second and second/third rounds of clinical trials in India. In addition to this, the company has also conducted Phase III active comparable clinical trials to evaluate its superiority over Covishield, the ministry said.

Also read- Election 2022: Keep these things in mind while voting in EVM, in this way check whether your vote has gone to the right place or not?

Read also- Election 2022: Now you will not have to stand in long lines for voting, in this way you can cast your vote sitting at home



Please enter your comment!
Please enter your name here